Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 2
2005 1
2009 2
2011 3
2012 2
2013 3
2014 5
2015 7
2016 4
2017 6
2018 1
2019 7
2020 13
2021 8
2022 8
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Transanal TME: new standard or fad?
Hasegawa S, Yoshida Y, Morimoto M, Kojima D, Komono A, Aisu N, Taketomi H, Nagano H, Matsumoto Y, Munechika T, Kajitani R. Hasegawa S, et al. Among authors: yoshida y. J Anus Rectum Colon. 2019 Jan 29;3(1):1-9. doi: 10.23922/jarc.2018-030. eCollection 2019. J Anus Rectum Colon. 2019. PMID: 31559361 Free PMC article. Review.
Cisplatin resistance and transcription factors.
Torigoe T, Izumi H, Ishiguchi H, Yoshida Y, Tanabe M, Yoshida T, Igarashi T, Niina I, Wakasugi T, Imaizumi T, Momii Y, Kuwano M, Kohno K. Torigoe T, et al. Among authors: yoshida y. Curr Med Chem Anticancer Agents. 2005 Jan;5(1):15-27. doi: 10.2174/1568011053352587. Curr Med Chem Anticancer Agents. 2005. PMID: 15720258 Review.
Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study).
Matsuoka H, Yamada T, Ohta R, Yoshida Y, Watanabe T, Takahashi M, Kosugi C, Fukazawa A, Kuramochi H, Matsuda A, Sonoda H, Yoshida H, Hasegawa S, Sakamoto K, Otsuka T, Hirata K, Koda K; TAS CC4 Study Group. Matsuoka H, et al. Among authors: yoshida y. Int J Clin Oncol. 2022 Dec;27(12):1859-1866. doi: 10.1007/s10147-022-02243-4. Epub 2022 Oct 6. Int J Clin Oncol. 2022. PMID: 36201089 Clinical Trial.
Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy.
Yoshida Y, Mogi A, Yamada T, Aisu N, Matsuoka T, Kojima D, Tanimura S, Koganemaru T, Oda M, Fukuda M, Kiyomi F, Noda K, Hirata K, Yamashita Y. Yoshida Y, et al. Springerplus. 2015 Dec 30;4:822. doi: 10.1186/s40064-015-1646-7. eCollection 2015. Springerplus. 2015. PMID: 26753110 Free PMC article.
80 results